Grace Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-23.0M | $-23.0M | — | $2.0M |
| FY2021 | $-14.3M | $-14.3M | — | $1.2M |
| FY2022 | $-17.2M | $-17.2M | — | $1.3M |
| FY2023 | $-15.9M | $-15.9M | — | $1.8M |
| FY2024 | $-12.3M | $-12.3M | — | $913.0K |
| FY2025 | $-14.9M | $-14.9M | — | $730.0K |
| FY2026 | $-8.9M | $-8.9M | — | $798.0K |